Purchase Agreement Melds Cellular Imaging and Cell Analysis Technologies

Applied Precision, which develops and manufactures high-resolution and super-resolution microscopy instruments with accompanying software and data visualization tools, has 130 employees and had estimated 2010 revenues of approximately $37 million.

Applied Precision's proprietary technologies are complementary to GE Healthcare's IN Cell Analyzer Systems, which are used for high-throughput subcellular analysis in cell biology research. Kieran Murphy, president and CEO of GE Healthcare Life Sciences, said, "Applied Precision is a company with a strong reputation for innovation and is a great strategic fit with our cell technologies business. The combination of GE Healthcare's expertise in cell science together with the great talent of the team at Applied Precision will help us drive development of new technologies and create an extensive offering across the full spectrum of cell biology research."

"We are very excited to become part of GE Healthcare's Life Sciences team," said Joe Victor, CEO of Applied Precision. "The worldwide resources of GE Healthcare will allow us to significantly widen our reach into new markets and provide a stronger support network for our existing customers. We are thrilled to have the opportunity to jointly develop new technologies, products, and applications for life sciences research. The entire Applied Precision team looks forward to joining GE."

Related Links:
GE Healthcare
Applied Precision